{
  "symbol": "SCLXW",
  "company_name": "Scilex Holding Company WT",
  "ir_website": "https://www.scilexholding.com/investors/overview",
  "structured_data": [
    {
      "section_name": "News & Events",
      "links": [
        {
          "title": "News & Events",
          "url": "https://www.scilexholding.com/investors/news-events",
          "content": "Search for: Search\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\nShopping cart [close](#)\n\n[ ![Scilex Holding](https://www.scilexholding.com/wp-content/uploads/2024/01/scilex-holding-logo-1.png) ](https://www.scilexholding.com/) [ ![Scilex Holding]() ](https://www.scilexholding.com/)\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\n![](https://www.scilexholding.com/wp-content/uploads/2024/02/Technology-3.png)\n\n# NEWS & EVENTS\n\n  * [ ](#)\n    * [ Investors Overview ](/investors/overview/)\n    * [ News & Events ](/investors/news-events/)\n    * [ Presentations ](/investors/presentations/)\n\n\n\n  * [ ](#)\n    * [ SEC Filings ](/investors/sec-filings/)\n    * [ Governance ](/investors/governance/)\n    * [ Sustainability ](/investors/sustainability/)\n\n\n\n  * [ ](#)\n    * [ Analyst Coverage ](/analyst-coverage-2/)\n    * [ Contact Investor Relations ](/investors/contact-investor-relations)\n    * [ Stock Information ](/investors/stock/)\n    * [ FAQs ](/investors/faqs/)\n\n\n\n# Email Alert\n\n![]()\n\n  * [](# \"Chinese \\(Simplified\\)\")\n  * [](# \"English\")\n  * [](# \"Japanese\")\n\n\n\n[Scroll To Top](#)\n\nWe use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies. \n\n[Accept](#) [More info](https://www.scilexholding.com/privacy-policy)\n\n[](javascript:; \"Close\")[](javascript:; \"Next\")[](javascript:; \"Previous\")\n"
        }
      ]
    },
    {
      "section_name": "Presentations",
      "links": [
        {
          "title": "Presentations",
          "url": "https://www.scilexholding.com/investors/presentations",
          "content": "Search for: Search\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\nShopping cart [close](#)\n\n[ ![Scilex Holding](https://www.scilexholding.com/wp-content/uploads/2024/01/scilex-holding-logo-1.png) ](https://www.scilexholding.com/) [ ![Scilex Holding]() ](https://www.scilexholding.com/)\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\n![](https://www.scilexholding.com/wp-content/uploads/2024/02/Pipeline-2.png)\n\n# PRESENTATIONS\n\n  * [ ](#)\n    * [ Investors Overview ](/investors/overview/)\n    * [ News & Events ](/investors/news-events/)\n    * [ Presentations ](/investors/presentations/)\n\n\n\n  * [ ](#)\n    * [ SEC Filings ](/investors/sec-filings/)\n    * [ Governance ](/investors/governance/)\n    * [ Sustainability ](/investors/sustainability/)\n\n\n\n  * [ ](#)\n    * [ Analyst Coverage ](/analyst-coverage-2/)\n    * [ Contact Investor Relations ](/investors/contact-investor-relations)\n    * [ Stock Information ](/investors/stock/)\n    * [ FAQs ](/investors/faqs/)\n\n\n\n[![](https://www.scilexholding.com/wp-content/uploads/2023/06/presentation-png.png)](https://www.scilexholding.com/wp-content/uploads/2024/09/Scilex-Corporate-Presentation.pdf)\n\n# Email Alert\n\n![]()\n\n  * [](# \"Chinese \\(Simplified\\)\")\n  * [](# \"English\")\n  * [](# \"Japanese\")\n\n\n\nSelect LanguageChinese (Simplified)Japanese\n\nPowered by [![Google Translate](https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_42x16dp.png)Translate](https://translate.google.com)\n\n[Scroll To Top](#)\n\nWe use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies. \n\n[Accept](#) [More info](https://www.scilexholding.com/privacy-policy)\n\n![](https://fonts.gstatic.com/s/i/productlogos/translate/v14/24px.svg)\n\nOriginal text\n\nRate this translation\n\nYour feedback will be used to help improve Google Translate\n\n[](javascript:; \"Close\")[](javascript:; \"Next\")[](javascript:; \"Previous\")\n"
        }
      ]
    },
    {
      "section_name": "SEC Filings",
      "links": [
        {
          "title": "SEC Filings",
          "url": "https://www.scilexholding.com/investors/sec-filings",
          "content": "Search for: Search\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\nShopping cart [close](#)\n\n[ ![Scilex Holding](https://www.scilexholding.com/wp-content/uploads/2024/01/scilex-holding-logo-1.png) ](https://www.scilexholding.com/) [ ![Scilex Holding]() ](https://www.scilexholding.com/)\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\n![](https://www.scilexholding.com/wp-content/uploads/2024/02/Career-4.png)\n\n# SEC FILINGS\n\n  * [ ](#)\n    * [ Investors Overview ](/investors/overview/)\n    * [ News & Events ](/investors/news-events/)\n    * [ Presentations ](/investors/presentations/)\n\n\n\n  * [ ](#)\n    * [ SEC Filings ](/investors/sec-filings/)\n    * [ Governance ](/investors/governance/)\n    * [ Sustainability ](/investors/sustainability/)\n\n\n\n  * [ ](#)\n    * [ Analyst Coverage ](/analyst-coverage-2/)\n    * [ Contact Investor Relations ](/investors/contact-investor-relations)\n    * [ Stock Information ](/investors/stock/)\n    * [ FAQs ](/investors/faqs/)\n\n\n\n# Email Alert\n\n![](https://www.scilexholding.com/wp-content/uploads/2024/02/5-layers-3-2.png)\n\n  * [](# \"Chinese \\(Simplified\\)\")\n  * [](# \"English\")\n  * [](# \"Japanese\")\n\n\n\nPowered by [![Google Translate](https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_42x16dp.png)Translate](https://translate.google.com)\n\n[Scroll To Top](#)\n\nWe use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies. \n\n[Accept](#) [More info](https://www.scilexholding.com/privacy-policy)\n\n![](https://fonts.gstatic.com/s/i/productlogos/translate/v14/24px.svg)\n\nOriginal text\n\nRate this translation\n\nYour feedback will be used to help improve Google Translate\n\n[](javascript:; \"Close\")[](javascript:; \"Next\")[](javascript:; \"Previous\")\n"
        }
      ]
    },
    {
      "section_name": "Governance",
      "links": [
        {
          "title": "Governance",
          "url": "https://www.scilexholding.com/investors/governance",
          "content": "Search for: Search\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\nShopping cart [close](#)\n\n[ ![Scilex Holding](https://www.scilexholding.com/wp-content/uploads/2024/01/scilex-holding-logo-1.png) ](https://www.scilexholding.com/) [ ![Scilex Holding]() ](https://www.scilexholding.com/)\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\n![](https://www.scilexholding.com/wp-content/uploads/2024/02/Career-2.jpg)\n\n# GOVERNANCE\n\n  * [ ](#)\n    * [ Investors Overview ](/investors/overview/)\n    * [ News & Events ](/investors/news-events/)\n    * [ Presentations ](/investors/presentations/)\n\n\n\n  * [ ](#)\n    * [ SEC Filings ](/investors/sec-filings/)\n    * [ Governance ](/investors/governance/)\n    * [ Sustainability ](/investors/sustainability/)\n\n\n\n  * [ ](#)\n    * [ Analyst Coverage ](/analyst-coverage-2/)\n    * [ Contact Investor Relations ](/investors/contact-investor-relations)\n    * [ Stock Information ](/investors/stock/)\n    * [ FAQs ](/investors/faqs/)\n\n\n\n# Corporate Governance Overview\n\nThe Board of Directors of Scilex Holding (the “Company”) sets high standards for the Company’s employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company’s business. The Board has adopted clear corporate policies that promote excellence in corporate governance. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.\n\n# Governance Documents\n\n[![icon-pdf](/wp-content/uploads/2022/11/icon-pdf.png) Corporate Governance Guidelines](/wp-content/uploads/2022/11/Scilex-Holding-Company-Corporate-Governance-Guidelines-Effective-11.10.2022.pdf)\n\n[![icon-pdf](/wp-content/uploads/2022/11/icon-pdf.png)](/wp-content/uploads/2022/11/Scilex-Holding-Company-Code-of-Business-Conduct-and-Ethics-Effective-11.10.2022.pdf) [Code of Business Conduct](/wp-content/uploads/2022/11/Scilex-Holding-Company-Code-of-Business-Conduct-and-Ethics-Effective-11.10.2022.pdf)\n\n[![](/wp-content/uploads/2022/11/icon-pdf.png)](/wp-content/uploads/2021/07/SCILEX-Comprehensive-Compliance-Program.pdf) [SCILEX Comprehensive Compliance Program](/wp-content/uploads/2021/07/SCILEX-Comprehensive-Compliance-Program.pdf)\n\n# California Compliance\n\n[![](/wp-content/uploads/2022/11/icon-pdf.png)](/wp-content/uploads/2021/10/SCILEX-Annual-Declaration-of-Compliance-Notice-2021.pdf) [Declaration of CA Compliance Program](/wp-content/uploads/2021/10/SCILEX-Annual-Declaration-of-Compliance-Notice-2021.pdf)\n\n[![](/wp-content/uploads/2022/11/icon-pdf.png)](/wp-content/uploads/2021/09/SCILEX-California-Transparency-In-Supply-Chain-Act.pdf) [California Transparency in Supply Chain Act](/wp-content/uploads/2021/09/SCILEX-California-Transparency-In-Supply-Chain-Act.pdf)\n\n# Committee Charters\n\n[![icon-pdf](/wp-content/uploads/2022/11/icon-pdf.png)](/wp-content/uploads/2022/11/Scilex-Holding-Company-Compensation-Committee-Charter-Effective-11.10.2022.pdf) [Compensation Committee Charter](/wp-content/uploads/2022/11/Scilex-Holding-Company-Compensation-Committee-Charter-Effective-11.10.2022.pdf)\n\n[![icon-pdf](/wp-content/uploads/2022/11/icon-pdf.png)](/wp-content/uploads/2022/11/Scilex-Holding-Company-Nominating-and-Corporate-Governance-Committee-Charter-Effective-11.10.2022.pdf) [Nominating Committee Charter](/wp-content/uploads/2022/11/Scilex-Holding-Company-Nominating-and-Corporate-Governance-Committee-Charter-Effective-11.10.2022.pdf)\n\n[![icon-pdf](/wp-content/uploads/2022/11/icon-pdf.png)](/wp-content/uploads/2022/11/Scilex-Holding-Company-Audit-Committee-Charter-Effective-11.10.2022.pdf) [Audit Committee Charter](/wp-content/uploads/2022/11/Scilex-Holding-Company-Audit-Committee-Charter-Effective-11.10.2022.pdf)\n\n# Committee Composition\n\n**NAME** | **Audit Committee** | **Compensation Committee** | **Governance** & **Nominating Committee** | **Commercialization** & **Transaction Committee**  \n---|---|---|---|---  \nDorman Followwill | XX | XX | XX  \nHenry Ji | X  \nJaisim Shah | XX  \nYue Alexander Wu | X | X | X  \nJay Chun | X | X  \nAnnu Navani | X  \nXX – denotes Chair X – denotes member\n\n# Email Alert\n\n![]()\n\n  * [](# \"Chinese \\(Simplified\\)\")\n  * [](# \"English\")\n  * [](# \"Japanese\")\n\n\n\nSelect LanguageChinese (Simplified)Japanese\n\nPowered by [![Google Translate](https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_42x16dp.png)Translate](https://translate.google.com)\n\n[Scroll To Top](#)\n\nWe use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies. \n\n[Accept](#) [More info](https://www.scilexholding.com/privacy-policy)\n\n![](https://fonts.gstatic.com/s/i/productlogos/translate/v14/24px.svg)\n\nOriginal text\n\nRate this translation\n\nYour feedback will be used to help improve Google Translate\n\n[](javascript:; \"Close\")[](javascript:; \"Next\")[](javascript:; \"Previous\")\n"
        }
      ]
    },
    {
      "section_name": "Sustainability",
      "links": [
        {
          "title": "Sustainability",
          "url": "https://www.scilexholding.com/investors/sustainability",
          "content": "Search for: Search\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\nShopping cart [close](#)\n\n[ ![Scilex Holding](https://www.scilexholding.com/wp-content/uploads/2024/01/scilex-holding-logo-1.png) ](https://www.scilexholding.com/) [ ![Scilex Holding]() ](https://www.scilexholding.com/)\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\n![](https://www.scilexholding.com/wp-content/uploads/2024/07/SUSTAINABILITY.jpg)\n\n# Sustainability\n\n  * [ ](#)\n    * [ Investors Overview ](/investors/overview/)\n    * [ News & Events ](/investors/news-events/)\n    * [ Presentations ](/investors/presentations/)\n\n\n\n  * [ ](#)\n    * [ SEC Filings ](/investors/sec-filings/)\n    * [ Governance ](/investors/governance/)\n    * [ Sustainability ](/investors/sustainability/)\n\n\n\n  * [ ](#)\n    * [ Analyst Coverage ](/analyst-coverage-2/)\n    * [ Contact Investor Relations ](/investors/contact-investor-relations)\n    * [ Stock Information ](/investors/stock/)\n    * [ FAQs ](/investors/faqs/)\n\n\n\n  * [Scilex Holding Company Sustainability Report](https://www.scilexholding.com/wp-content/uploads/2024/08/Scilex-Holding-company-sustainability-Report-ver17.pdf)\n\n\n\n# Email Alert\n\n![](https://www.scilexholding.com/wp-content/uploads/2024/02/5-layers-3-2.png)\n\n  * [](# \"Chinese \\(Simplified\\)\")\n  * [](# \"English\")\n  * [](# \"Japanese\")\n\n\n\nSelect LanguageChinese (Simplified)Japanese\n\nPowered by [![Google Translate](https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_42x16dp.png)Translate](https://translate.google.com)\n\n[Scroll To Top](#)\n\nWe use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies. \n\n[Accept](#) [More info](https://www.scilexholding.com/privacy-policy)\n\n![](https://fonts.gstatic.com/s/i/productlogos/translate/v14/24px.svg)\n\nOriginal text\n\nRate this translation\n\nYour feedback will be used to help improve Google Translate\n\n[](javascript:; \"Close\")[](javascript:; \"Next\")[](javascript:; \"Previous\")\n"
        }
      ]
    },
    {
      "section_name": "Analyst Coverage",
      "links": [
        {
          "title": "Analyst Coverage",
          "url": "https://www.scilexholding.com/analyst-coverage-2",
          "content": "Search for: Search\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\nShopping cart [close](#)\n\n[ ![Scilex Holding](https://www.scilexholding.com/wp-content/uploads/2024/01/scilex-holding-logo-1.png) ](https://www.scilexholding.com/) [ ![Scilex Holding]() ](https://www.scilexholding.com/)\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\n![](https://www.scilexholding.com/wp-content/uploads/2024/02/Career-1-1.jpg)\n\n# ANALYST COVERAGE\n\n  * [ ](#)\n    * [ Investors Overview ](/investors/overview/)\n    * [ News & Events ](/investors/news-events/)\n    * [ Presentations ](/investors/presentations/)\n\n\n\n  * [ ](#)\n    * [ SEC Filings ](/investors/sec-filings/)\n    * [ Governance ](/investors/governance/)\n    * [ Sustainability ](/investors/sustainability/)\n\n\n\n  * [ ](#)\n    * [ Analyst Coverage ](/analyst-coverage-2/)\n    * [ Contact Investor Relations ](/investors/contact-investor-relations)\n    * [ Stock Information ](/investors/stock/)\n    * [ FAQs ](/investors/faqs/)\n\n\n\nScilex is covered by the following analysts:\n\n**Firm** | **Analyst Name**  \n---|---  \nH.C. Wainright & Co. | Ram Selvaraju  \nRodman & Renshaw | Elemer Pieros  \nB. Riley | Mayank Mamtani  \nZacks | Brad Sorensen  \nAlliance Global Partners | James Molloy  \n  \n**December 10th 2024** Zacks reiterates buy rating for Scilex with PT $6.25 [Read More](https://www.scilexholding.com/wp-content/uploads/2024/12/Zacks_SCR_Research_12102024_SCLX_Sorensen.pdf)\n\n**October 21st, 2024** H.C.WAINWRIGHT & CO. Analyst reiterates buy rating with PT $7.00 [Read More](https://www.scilexholding.com/wp-content/uploads/2024/10/HCW.pdf)\n\n**October 16th 2024** Alliance Global partners initiates buy rating for Scilex with PT $14. [Read More](https://www.scilexholding.com/wp-content/uploads/2024/10/SCLX_2024-10-16.pdf)\n\n**October 14th 2024** Rodman and Renshaw reiterates buy rating for Scilex with PT $13 as Scilex announces inline preliminary numbers. [Read More](https://www.scilexholding.com/wp-content/uploads/2024/10/ScilexUpdates-RodmanRenshaw12-14-2024.pdf)\n\n**October 10th 2024** Zacks reiterates buy rating for Scilex with PT $5.50 [Read More](https://www.scilexholding.com/wp-content/uploads/2024/10/Zacks_SCR_Research_10102024_SCLX_Sorensen.pdf)\n\n**September 4th 2024** Zacks reiterates buy rating for Scilex with PT $5.50 [Read More](https://www.scilexholding.com/wp-content/uploads/2024/09/Zacks_SCR_Research_09042024_SCLX_Sorensen.pdf)\n\n**August 14th 2024** Zacks reiterates buy rating for Scilex with PT $5.50 [Read More](https://www.scilexholding.com/wp-content/uploads/2024/08/Zacks_SCR_Research_08142024_SCLX_Sorensen.pdf)\n\n**July 1st 2024** Rodman and Renshaw reiterates buy rating for Scilex with PT $13 as Scilex announces inline preliminary numbers. [Read More](https://www.scilexholding.com/wp-content/uploads/2024/07/rodman1.pdf)\n\n**June 17th 2024** H.C.WAINRIGHT & CO. reiterates buy rating for Scilex with PT $7.00; states strategic financing alleviates overhang, [Read More](https://www.scilexholding.com/wp-content/uploads/2024/06/EmailDocViewer.pdf)\n\n**June 14th 2024** B. Riley Securities reiterates buy rating for Scilex Holding with PT $4.00 citing strategic financing deal. [Read More](https://www.scilexholding.com/wp-content/uploads/2024/06/SCLX_2024-06-14.pdf)\n\n**June 12th 2024** Rodman and Renshaw reiterates buy rating for Scilex with PT $13 as major overhang is resolved. [Read More](https://www.scilexholding.com/wp-content/uploads/2024/06/rodman-1.pdf)\n\n**June 11th 2024** Zacks reiterates buy rating for Scilex with PT $5.00 [Read More](https://www.scilexholding.com/wp-content/uploads/2024/06/Zacks_SCR_Research_06112024_SCLX_Sorensen.pdf)\n\n**June 11th 2024** H.C.WAINRIGHT & CO. reiterates buy rating for Scilex with PT $7.00 [Read More](https://www.scilexholding.com/wp-content/uploads/2024/06/HCW1.pdf)\n\n**June 7th 2024** Rodman and Renshaw reiterates buy rating for Scilex with PT $13 [Read More](https://www.scilexholding.com/wp-content/uploads/2024/06/rodman.pdf)\n\n**May 14th 2024** Zacks reiterates buy rating for Scilex with PT $4.50 [Read More](https://www.scilexholding.com/wp-content/uploads/2024/05/Zacks_SCR_Research_05142024_SCLX_Sorensen.pdf)\n\n**May 06th 2024** H.C.WAINRIGHT & CO. reiterates buy rating for Scilex with PT $8.00 [Read More](https://www.scilexholding.com/wp-content/uploads/2024/05/HCW-May6.pdf)\n\n**April 29th 2024** Rodman and Renshaw reiterate buy rating with PT of 13.00 [Read More](https://www.scilexholding.com/wp-content/uploads/2024/04/UnfoundedOptimismAboutaCompetitor.pdf)\n\n**April 16th 2024** Rodman and Renshaw initiates reiterate buy rating for Scilex with PT $14 [Read More](https://www.scilexholding.com/wp-content/uploads/2024/04/rodman.pdf)\n\n**April 8th 2024** Rodman and Renshaw initiates buy rating for Scilex with PT $14 [Read More](https://www.scilexholding.com/wp-content/uploads/2024/04/SCLX-Initiation-by-Rodman-4-8-24.pdf)\n\n**March 5th 2024** Zacks reiterates buy rating for Scilex with PT $4.50 [Read More](/wp-content/uploads/2024/03/Zacks_SCR_Research_03052024.pdf)\n\n**February 18th 2024** Zacks reiterates buy rating for Scilex with PT $4.75 [Read More](/wp-content/uploads/2024/02/Zacks_SCR_Research_01302024_SCLX_Sorensen.pdf)\n\n**January 26th 2024** B. Riley Securities reiterates buy rating for Scilex Holding with PT $4.00 [Read More](/wp-content/uploads/2024/02/SCLX_2024-01-26.pdf)\n\n**January 23rd 2024** H.C.WAINRIGHT & CO. reiterates buy coverage for Scilex with PT $12 [Read More](/wp-content/uploads/2024/02/HCW-dec04.pdf)\n\n**December 4th 2023** H.C.WAINRIGHT & CO. reiterates buy coverage for Scilex [Read More](/wp-content/uploads/2023/12/HCW-dec04.pdf)\n\n**November 24th 2023** B. Riley Securities reiterates buy rating for Scilex Holding with PT $4.00 [Read More](/wp-content/uploads/2023/11/BRiley-11242023.pdf)\n\n**November 15th 2023** Zacks reiterates buy rating for Scilex with PT $4.75 [Read More](/wp-content/uploads/2023/11/Zacks_SCR_Research_11152023_SCLX_Sorensen.pdf)\n\n**November 7th 2023** H.C.WAINRIGHT & CO. reiterates buy coverage for Scilex [Read More](/wp-content/uploads/2023/11/HCwainright2.pdf)\n\n**October 26, 2023** Zacks initiates coverage [Read More](/wp-content/uploads/2023/10/Zacks-analyst-report-October-26-2023.pdf)\n\n**October 23, 2023** B. Riley Securities initiates coverage [Read More](https://www.scilexholding.com/wp-content/uploads/2024/04/SCLX-Initiation-by-Rodman-4-8-24.pdf)\n\n**October 9th, 2023** H.C.WAINWRIGHT & CO. Analyst initiates coverage [Read More](/wp-content/uploads/2023/10/analyst-coverage.pdf)\n\n# Email Alert\n\n![]()\n\n  * [](# \"Chinese \\(Simplified\\)\")\n  * [](# \"English\")\n  * [](# \"Japanese\")\n\n\n\n[Scroll To Top](#)\n\nWe use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies. \n\n[Accept](#) [More info](https://www.scilexholding.com/privacy-policy)\n\n[](javascript:; \"Close\")[](javascript:; \"Next\")[](javascript:; \"Previous\")\n"
        }
      ]
    },
    {
      "section_name": "Contact Investor Relations",
      "links": [
        {
          "title": "Contact Investor Relations",
          "url": "https://www.scilexholding.com/investors/contact-investor-relations",
          "content": "Search for: Search\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\nShopping cart [close](#)\n\n[ ![Scilex Holding](https://www.scilexholding.com/wp-content/uploads/2024/01/scilex-holding-logo-1.png) ](https://www.scilexholding.com/) [ ![Scilex Holding]() ](https://www.scilexholding.com/)\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\n![](https://www.scilexholding.com/wp-content/uploads/2024/02/Contact.jpg)\n\n# CONTACT Investor Relations\n\n  * [ ](#)\n    * [ Investors Overview ](/investors/overview/)\n    * [ News & Events ](/investors/news-events/)\n    * [ Presentations ](/investors/presentations/)\n\n\n\n  * [ ](#)\n    * [ SEC Filings ](/investors/sec-filings/)\n    * [ Governance ](/investors/governance/)\n    * [ Sustainability ](/investors/sustainability/)\n\n\n\n  * [ ](#)\n    * [ Analyst Coverage ](/analyst-coverage-2/)\n    * [ Contact Investor Relations ](/investors/contact-investor-relations)\n    * [ Stock Information ](/investors/stock/)\n    * [ FAQs ](/investors/faqs/)\n\n\n\n# Contact Investor Relations\n\nFields marked with an * are required\n\nName * *\n\nPhone \n\nEmail * *\n\nSubject \n\nMessage * *\n\nRecaptcha \n\nIf you are a human seeing this field, please leave it empty. \n\n# Email Alert\n\n![](https://www.scilexholding.com/wp-content/uploads/2024/02/5-layers-3-2.png)\n\n  * [](# \"Chinese \\(Simplified\\)\")\n  * [](# \"English\")\n  * [](# \"Japanese\")\n\n\n\nPowered by [![Google Translate](https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_42x16dp.png)Translate](https://translate.google.com)\n\n[Scroll To Top](#)\n\nWe use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies. \n\n[Accept](#) [More info](https://www.scilexholding.com/privacy-policy)\n\n![](https://fonts.gstatic.com/s/i/productlogos/translate/v14/24px.svg)\n\nOriginal text\n\nRate this translation\n\nYour feedback will be used to help improve Google Translate\n\n[](javascript:; \"Close\")[](javascript:; \"Next\")[](javascript:; \"Previous\")\n"
        }
      ]
    },
    {
      "section_name": "Stock Information",
      "links": [
        {
          "title": "Stock Information",
          "url": "https://www.scilexholding.com/investors/stock",
          "content": "Search for: Search\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\nShopping cart [close](#)\n\n[ ![Scilex Holding](https://www.scilexholding.com/wp-content/uploads/2024/01/scilex-holding-logo-1.png) ](https://www.scilexholding.com/) [ ![Scilex Holding]() ](https://www.scilexholding.com/)\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\n![](https://www.scilexholding.com/wp-content/uploads/2024/02/Career-5.png)\n\n# STOCK INFORMATION\n\n  * [ ](#)\n    * [ Investors Overview ](/investors/overview/)\n    * [ News & Events ](/investors/news-events/)\n    * [ Presentations ](/investors/presentations/)\n\n\n\n  * [ ](#)\n    * [ SEC Filings ](/investors/sec-filings/)\n    * [ Governance ](/investors/governance/)\n    * [ Sustainability ](/investors/sustainability/)\n\n\n\n  * [ ](#)\n    * [ Analyst Coverage ](/analyst-coverage-2/)\n    * [ Contact Investor Relations ](/investors/contact-investor-relations)\n    * [ Stock Information ](/investors/stock/)\n    * [ FAQs ](/investors/faqs/)\n\n\n\n# Stock Quote\n\n# Stock Chart\n\nData Provided by Refinitiv. Minimum 15 minutes delayed.\n\n# Email Alert\n\n![]()\n\n  * [](# \"Chinese \\(Simplified\\)\")\n  * [](# \"English\")\n  * [](# \"Japanese\")\n\n\n\n[Scroll To Top](#)\n\nWe use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies. \n\n[Accept](#) [More info](https://www.scilexholding.com/privacy-policy)\n\n[](javascript:; \"Close\")[](javascript:; \"Next\")[](javascript:; \"Previous\")\n"
        }
      ]
    },
    {
      "section_name": "FAQs",
      "links": [
        {
          "title": "FAQs",
          "url": "https://www.scilexholding.com/investors/faqs",
          "content": "Search for: Search\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\nShopping cart [close](#)\n\n[ ![Scilex Holding](https://www.scilexholding.com/wp-content/uploads/2024/01/scilex-holding-logo-1.png) ](https://www.scilexholding.com/) [ ![Scilex Holding]() ](https://www.scilexholding.com/)\n\n  * [About](https://www.scilexholding.com/about)\n\n    * [Overview](/about/#overview)\n    * [Leadership](/about/#leadership)\n    * [Board Of Directors](/about/#boardofdirectors)\n    * [Our Culture](/about/#ourculture)\n    * [Gallery](https://www.scilexholding.com/about/event-gallery)\n\n  * [Product Portfolio](https://www.scilexholding.com/technology)\n\n    * [Technology](https://www.scilexholding.com/technology)\n    * [Pipeline](https://www.scilexholding.com/technology/pipeline)\n    * [ZTLido®](https://www.ztlido.com/)\n    * [Elyxyb®](https://www.elyxyb.com/)\n    * [Gloperba®](https://www.gloperba.com/)\n    * [Expanded Access Policy](https://www.scilexholding.com/technology/expanded-access-policy)\n\n  * [Partners](https://www.scilexholding.com/partners)\n  * [Science](https://www.scilexholding.com/medical-information-u-s)\n\n    * [Medical information U.S.](https://www.scilexholding.com/medical-information-u-s)\n    * [Publications](https://www.scilexholding.com/publications)\n\n  * [Investors](https://www.scilexholding.com/investors/overview)\n\n    * [Investors Overview](https://www.scilexholding.com/investors/overview)\n    * [News & Events](https://www.scilexholding.com/investors/news-events)\n    * [Presentations](https://www.scilexholding.com/investors/presentations)\n    * [SEC Filings](https://www.scilexholding.com/investors/sec-filings)\n    * [Governance](https://www.scilexholding.com/investors/governance)\n    * [Sustainability](https://www.scilexholding.com/investors/sustainability)\n    * [Analyst Coverage](https://www.scilexholding.com/analyst-coverage-2)\n    * [Contact Investor Relations](https://www.scilexholding.com/investors/contact-investor-relations)\n    * [Stock Information](https://www.scilexholding.com/investors/stock)\n    * [FAQs](https://www.scilexholding.com/investors/faqs)\n\n  * [Join Our Team](https://www.scilexholding.com/join-our-team)\n  * [Contact Us](https://www.scilexholding.com/contact-us)\n\n    * [Contact Us](https://www.scilexholding.com/contact-us)\n    * [Locations](/contact-us/#locations)\n\n  * [](#)[](# \"English\")[](# \"Chinese \\(Simplified\\)\")[](# \"Japanese\")\n\n\n\n![](https://www.scilexholding.com/wp-content/uploads/2024/02/Career-8.png)\n\n# FREQUENTLY ASKED QUESTIONS\n\n  * [ ](#)\n    * [ Investors Overview ](/investors/overview/)\n    * [ News & Events ](/investors/news-events/)\n    * [ Presentations ](/investors/presentations/)\n\n\n\n  * [ ](#)\n    * [ SEC Filings ](/investors/sec-filings/)\n    * [ Governance ](/investors/governance/)\n    * [ Sustainability ](/investors/sustainability/)\n\n\n\n  * [ ](#)\n    * [ Analyst Coverage ](/analyst-coverage-2/)\n    * [ Contact Investor Relations ](/investors/contact-investor-relations)\n    * [ Stock Information ](/investors/stock/)\n    * [ FAQs ](/investors/faqs/)\n\n\n\n# Frequently Asked Questions\n\n  * Click to download\n  * [Download to Learn More Regarding the Dividend of Scilex Holding Company Common Stock](/wp-content/uploads/2024/02/STI-Dividend-FAQ-for-Scilex_s-Website115095612_1.pdf)\n  * [Scilex Supplement to Dividend FAQ](/wp-content/uploads/2024/02/2023-02-01-Scilex-Supplement-to-Dividend-FAQ-for-Scilex_s-Website115122443_1.pdf)\n  * [Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock](https://scilexholding.gcs-web.com/node/8591/pdf)\n  * [Scilex Holding Company Anounces thathe U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorento to its Stockholders as a Dividend Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend](https://www.scilexholding.com/wp-content/uploads/2024/03/Scilex-Holding-Company-Announces-that-the-U.S.-Bankruptcy-Court-has-Extended-the-Lockup-Period-on-Shares-of-Scilex-Stock-Previously-Distributed-by-Sorrento-to-its-Stockholders-as-a-Dividend.pdf)\n  * [Order Extending The Application Of The Automatic Stay To Continue The Restricted Trading Period For Shares Of Scilex Stock Distributed To The Debtors’ Shareholders](https://www.scilexholding.com/wp-content/uploads/2024/03/Order-Extending-The-Application-Of-The-Automatic-Stay-To-Continue-The-Restricted-Trading-Period-For-Shares-Of-Scilex-Stock-Distributed-To-The-Debtors-Shareholders.pdf)\n\n\n\n# Email Alert\n\n![]()\n\n  * [](# \"Chinese \\(Simplified\\)\")\n  * [](# \"English\")\n  * [](# \"Japanese\")\n\n\n\nPowered by [![Google Translate](https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_42x16dp.png)Translate](https://translate.google.com)\n\n[Scroll To Top](#)\n\nWe use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies. \n\n[Accept](#) [More info](https://www.scilexholding.com/privacy-policy)\n\n![](https://fonts.gstatic.com/s/i/productlogos/translate/v14/24px.svg)\n\nOriginal text\n\nRate this translation\n\nYour feedback will be used to help improve Google Translate\n\n[](javascript:; \"Close\")[](javascript:; \"Next\")[](javascript:; \"Previous\")\n"
        }
      ]
    }
  ]
}